List of Studies ( Metabolite:Citric acid/Isocitric acid)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003788 | AN006226 | Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality | Cerebrospinal fluid | Human | Tuberculosis; Meningitis | Broad Institute of MIT and Harvard | LC-MS |
| ST003588 | AN005892 | Mitochondria complex III is essential for IL-10 secretion in macrophages independent of respiration | Macrophages | Mouse | Influenza | Northwestern University, Feinberg School of Medicine | LC-MS |
| ST003588 | AN005892 | Mitochondria complex III is essential for IL-10 secretion in macrophages independent of respiration | Macrophages | Mouse | Toxic shock | Northwestern University, Feinberg School of Medicine | LC-MS |
| ST003551 | AN005837 | Metabolomics analysis of N-methyl-arginine-treated HEK293 control (sgTomato) and ALDH7A1-deficient (sgALDH7A1) cells. | Cultured cells | Human | University of British Columbia | LC-MS | |
| ST003551 | AN005838 | Metabolomics analysis of N-methyl-arginine-treated HEK293 control (sgTomato) and ALDH7A1-deficient (sgALDH7A1) cells. | Cultured cells | Human | University of British Columbia | LC-MS | |
| ST003549 | AN005833 | Metabolomics analysis of kidney, brain, liver, and plasma from Aldh7a1-/- and Aldh7a1+/+ mice. | Blood | Mouse | Metabolic Disorders | University of British Columbia | LC-MS |
| ST003549 | AN005833 | Metabolomics analysis of kidney, brain, liver, and plasma from Aldh7a1-/- and Aldh7a1+/+ mice. | Tissue | Mouse | Metabolic Disorders | University of British Columbia | LC-MS |
| ST003549 | AN005834 | Metabolomics analysis of kidney, brain, liver, and plasma from Aldh7a1-/- and Aldh7a1+/+ mice. | Blood | Mouse | Metabolic Disorders | University of British Columbia | LC-MS |
| ST003549 | AN005834 | Metabolomics analysis of kidney, brain, liver, and plasma from Aldh7a1-/- and Aldh7a1+/+ mice. | Tissue | Mouse | Metabolic Disorders | University of British Columbia | LC-MS |
| ST003492 | AN005732 | Metabolomic profiling of the secretome in normal primary human pulmonary artery smooth muscle cells | Vascular smooth muscle cells | Human | Peking University | MALDI | |
| ST003438 | AN005651 | Unbiased genetic screening and metabolomics identifies glial adenosine metabolism as a therapeutic target in Parkinson’s disease | Fly Head | Fruit fly | Parkinsons disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003436 | AN005645 | Pharmacokinetics of Fasnall in NSG mice | Blood | Mouse | Cancer | Wistar Institute | LC-MS |
| ST003436 | AN005645 | Pharmacokinetics of Fasnall in NSG mice | Brain | Mouse | Cancer | Wistar Institute | LC-MS |
| ST003436 | AN005645 | Pharmacokinetics of Fasnall in NSG mice | Heart | Mouse | Cancer | Wistar Institute | LC-MS |
| ST003436 | AN005645 | Pharmacokinetics of Fasnall in NSG mice | Liver | Mouse | Cancer | Wistar Institute | LC-MS |
| ST003435 | AN005643 | Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 | Media | Zebrafish | Cancer | Wistar Institute | LC-MS |
| ST003434 | AN005641 | Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. | Blood | Human | Cancer | Wistar Institute | LC-MS |
| ST003433 | AN005639 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 | Cultured cells | Human | Cancer | Wistar Institute | LC-MS |
| ST003311 | AN005423 | Complementary Omics Analyses of The Brain Of A Kainic Acid Epilepsy Model Reveal Alterations In Purine And Energy Metabolism With Metabolic Implications for miRNA Cargos Within Milk-Exosomes | Brain | Mouse | Epilepsy | University of Nebraska-Lincoln | GC-MS |
| ST003297 | AN005401 | Metabolomic profiling of cultured TRAMP-C2 cells in the presence or absence of PD-L1. | Cultured cells | Mouse | Cancer | University of Ottawa | LC-MS |
| ST003088 | AN005051 | Metabolome changes in embryonic CSF (Part 10) | Blood | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003088 | AN005051 | Metabolome changes in embryonic CSF (Part 10) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003088 | AN005051 | Metabolome changes in embryonic CSF (Part 10) | Liver | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | LC-MS |
| ST003076 | AN005034 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism | Adipose tissue | Mouse | North Carolina State University | LC-MS | |
| ST003076 | AN005034 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism | Blood | Mouse | North Carolina State University | LC-MS | |
| ST003076 | AN005034 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism | Heart | Mouse | North Carolina State University | LC-MS | |
| ST003076 | AN005034 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism | Intestine | Mouse | North Carolina State University | LC-MS | |
| ST003076 | AN005034 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism | Kidney | Mouse | North Carolina State University | LC-MS | |
| ST003076 | AN005034 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism | Liver | Mouse | North Carolina State University | LC-MS | |
| ST003076 | AN005034 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism | Muscle | Mouse | North Carolina State University | LC-MS | |
| ST003063 | AN005018 | Uncoupling Metabolic Health from Thermogenesis via BCAA Nitrogen Flux in Brown Fat - Serum metabolomics from control and MBC UCP1-KO | Blood | Mouse | Diabetes | BIDMC | LC-MS |
| ST003060 | AN005015 | Fluxomics of hormone deprivation in ER+ breast cancer cell lines | Breast cancer cells | Human | Cancer | Dartmouth College | LC-MS |
| ST002936 | AN004816 | O-GlcNAcase activity maintains stress granules for proximity-enhanced ATP production to ensure recovery from stress (Part 2) | Cultured cells | Human | Zhejiang University | LC-MS | |
| ST002927 | AN004801 | O-GlcNAcase activity maintains stress granules for proximity-enhanced ATP production to ensure recovery from stress | Cultured cells | Human | Stress | Zhejiang University | LC-MS |
| ST002903 | AN004763 | Identification and targeting of microbial putrescine acetylation in bloodstream infections | Blood | Human | Septic shock | Broad Institute of MIT and Harvard | LC-MS |
| ST002878 | AN004716 | Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy. Dynamic Labelling experiment. | Embryonic cells | Mouse | Diabetes | University of California, Los Angeles | LC-MS |
| ST002852 | AN004673 | MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer | Prostate | Mouse | Cancer | University of California, Los Angeles | LC-MS |
| ST002835 | AN004631 | Investigation of FGFR signaling controlled metabolism in FGFR2-fusion+ intrahepatic cholangiocarcinoma | Tumor cells | Human | Cancer | Massachusetts General Hospital | LC-MS |
| ST002835 | AN004632 | Investigation of FGFR signaling controlled metabolism in FGFR2-fusion+ intrahepatic cholangiocarcinoma | Tumor cells | Human | Cancer | Massachusetts General Hospital | LC-MS |
| ST002814 | AN004706 | Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy | Embryonic cells | Mouse | Diabetes | University of California, Los Angeles | LC-MS |
| ST002813 | AN004576 | Effects of acute cold exposure on mouse metabolome | BAT | Mouse | University of Pennsylvania | LC-MS | |
| ST002813 | AN004576 | Effects of acute cold exposure on mouse metabolome | Blood | Mouse | University of Pennsylvania | LC-MS | |
| ST002813 | AN004576 | Effects of acute cold exposure on mouse metabolome | Diaphragm | Mouse | University of Pennsylvania | LC-MS | |
| ST002813 | AN004576 | Effects of acute cold exposure on mouse metabolome | gWAT | Mouse | University of Pennsylvania | LC-MS | |
| ST002813 | AN004576 | Effects of acute cold exposure on mouse metabolome | Heart | Mouse | University of Pennsylvania | LC-MS | |
| ST002813 | AN004576 | Effects of acute cold exposure on mouse metabolome | Liver | Mouse | University of Pennsylvania | LC-MS | |
| ST002813 | AN004576 | Effects of acute cold exposure on mouse metabolome | Quadriceps | Mouse | University of Pennsylvania | LC-MS | |
| ST002805 | AN004561 | IL-1β-mediated adaptive re-programming of endogenous human cardiac fibroblasts to cells with immune features during fibrotic remodeling | Cultured cells | Human | Pulmonary hypertension | Brown University | Other |
| ST002709 | AN004391 | FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer | Cultured cells | Human | Cancer | University of California, Los Angeles | LC-MS |
| ST002567 | AN004228 | Metabolomics of Human islets treated with DHT and high-glucose challenge | Pancreas | Human | Diabetes | Tulane University School of Medicine | LC-MS |
| ST002536 | AN004172 | Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma | Thyroid | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST002508 | AN004130 | 13C-isotopic labeling of mouse eye organoids under three conditions. | Retina | Mouse | Northwestern University | LC-MS | |
| ST002507 | AN004129 | Time-course analysis of C13 labeling in mouse eye organoids. | Retina | Mouse | Northwestern University | LC-MS | |
| ST002506 | AN004128 | Natural abundance of isotopic metabolite detection in mouse eye orgnaoids. | Retina | Mouse | Northwestern University | LC-MS | |
| ST002499 | AN004106 | Metabolomics analysis of stress erythroid progenitors (Part 2) | Stem cells | Mouse | Inflammation | Pennsylvania State University | LC-MS |
| ST002473 | AN004040 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Veillonella parvula media profiling of IBD drug metabolites | Culture media | Veillonella parvula | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002471 | AN004035 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling | Feces | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002470 | AN004031 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling | Blood | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002379 | AN003878 | Glucose flux analysis of NLRP3 inflammasome activated macrophages | Macrophages | Mouse | Wake Forest School of Medicine | LC-MS | |
| ST002378 | AN003876 | Targeted metabolomics analysis of WT and GSDMDKO macrophages | Macrophages | Mouse | Wake Forest School of Medicine | LC-MS | |
| ST002375 | AN003870 | Metabolomics analysis of WT or GOT1 knockout CD8+ T cells cultured in serine-replete or serine-free media | Cultured cells | Mouse | Johns Hopkins University | LC-MS | |
| ST002373 | AN003868 | Extracellular metabolome of activated CD8+ T cells | Cultured cells | Mouse | Johns Hopkins University | LC-MS | |
| ST002371 | AN003866 | High-resolution metabolomics analysis of NLRP3 inflammasome activated macrophages | Macrophages | Mouse | Inflammation | Wake Forest School of Medicine | GC-MS |
| ST002247 | AN003672 | Microbiota and Health Study (Dhaka, Bangladesh) | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST002246 | AN003668 | Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST002234 | AN003644 | A metabolic map of the DNA damage response identifies PRDX1 in nuclear ROS scavenging and aspartate synthesis | Cultured cells | Human | DNA damage response | CRG | LC-MS |
| ST002231 | AN003641 | Metabolomics Analysis of HOG-EV and HOG-R132H Cells with and without BAY 2402234 Treatment | Cultured cells | Human | Cancer | UT Southwestern Medical Center | LC-MS |
| ST002119 | AN003468 | Metabolomics analysis of zebrafish response to CID661578 treatment | Larvae | Zebrafish | Diabetes | North Carolina State University | LC-MS |
| ST002084 | AN003401 | A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy(Part 2) | Cultured cells | Human | Cancer | Yale University | LC-MS |
| ST002078 | AN003387 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003388 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003389 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003390 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002024 | AN003294 | Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003277 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003278 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003279 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002009 | AN003275 | Metabolomics analysis of stress erythroid progenitors | Stem cells | Mouse | Inflammation | Pennsylvania State University | LC-MS |
| ST002007 | AN003270 | Isotope tracing analysis of stress erythroid progenitors | Cultured cells | Mouse | Inflammation | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Blood | Human | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Cultured cells | Human | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001954 | AN003179 | A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s Ataxia | Yeast cells | Yeast | Friedreichs Ataxia | University of California, Los Angeles | LC-MS |
| ST001878 | AN003081 | Targeted analysis of Babesia divergens merozoites | Merozoites | Blood parasite | Universidad CEU San Pablo | LC-MS | |
| ST001709 | AN002784 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Human | COVID-19 | University of California, Los Angeles | LC-MS |
| ST001690 | AN002760 | Untargeted metabolomic analysis of human blood samples via qualitative GC-MS for T1D biomarker identification | Blood | Human | Diabetes | Duke University | GC-MS |
| ST001660 | AN002711 | Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001652 | AN002699 | Atypical Molecular Basis for Drug Resistance to Mitochondrial AQ: A Function Inhibitors in Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | U.S. Food & Drug Administration | LC-MS |
| ST001611 | AN002646 | Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment | Muscle | Mouse | Cancer | North Carolina State University | LC-MS |
| ST001611 | AN002646 | Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment | Sarcoma | Mouse | Cancer | North Carolina State University | LC-MS |
| ST001521 | AN002535 | Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) | Blood | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001519 | AN002527 | Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001441 | AN002408 | Metabolomics of patient-derived fibroblasts | Fibroblast cells | Human | Mitochondrial disease | North Carolina State University | LC-MS |
| ST001384 | AN002309 | Plasmodium falciparum increased time in circulation underlies persistent asymptomatic infection in the dry season | Blood | Human | Malaria | Pennsylvania State University | LC-MS |
| ST001382 | AN002303 | Distinct metabolic states of a cell guide alternate fates of mutational buffering through altered proteostasis | Bacterial cells | E. coli | CSIR-National Chemical Laboratory | LC-MS | |
| ST001320 | AN002196 | Examination of labeled glucose utilization in central carbon metabolism in HeLa cells post WNT stimulation | Cultured cells | Human | Cancer | University of California, Los Angeles | LC-MS |
| ST001299 | AN002163 | Metatranscriptomic Analysis of the Mouse Gut Microbiome Response to the Persistent Organic Pollutant 2,3,7,8-Tetrachlorodibenzofuran | Cecum | Mouse | Pennsylvania State University | LC-MS | |
| ST001287 | AN002148 | Luminal succinate in UC-HMA (human microbiota-associated) mice. | Feces | Mouse | University of Michigan | LC-MS | |
| ST001279 | AN002120 | K13 mutations driving artemisinin resistance rewrite Plasmodium falciparum’s programmed intra-erythrocytic development and transform mitochondrial physiology | Parasite | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001232 | AN002050 | Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001192 | AN001985 | A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Ileum | Pig | Sepsis | Indiana University School of Medicine | GC-MS |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Jejunum | Pig | Sepsis | Indiana University School of Medicine | GC-MS |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Liver | Pig | Sepsis | Indiana University School of Medicine | GC-MS |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Lung | Pig | Sepsis | Indiana University School of Medicine | GC-MS |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Muscle | Pig | Sepsis | Indiana University School of Medicine | GC-MS |
| ST001149 | AN001896 | Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001074 | AN001756 | Open source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1) | Parasite | Human | Pennsylvania State University | LC-MS | |
| ST001008 | AN001650 | Multi-Platform Physiologic and Metabolic Phenotyping Reveals Microbial Toxicity (part II) | Cecum | Mouse | Pennsylvania State University | LC-MS | |
| ST000925 | AN001518 | MuRF1-Related Metabolomic Changes in Stretched and Unloaded HL-1 Cells | Cardiomyocyte cells | Mouse | University of North Carolina at Chapel Hill | GC-MS | |
| ST000924 | AN001517 | MuRF1-Related Metabolic Alterations in HL-1 Cardiomyocyte Induced by Cyclic Stretch | Cultured cells | Mouse | University of North Carolina at Chapel Hill | LC-MS | |
| ST000897 | AN001459 | Untargeted metabolomics analysis of ischemia-reperfusion injured hearts ex vivo from sedentary and exercise trained rats. | Muscle | Rat | Heart injury | University of North Carolina at Chapel Hill | GC-MS |
| ST000896 | AN001458 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Muscle Metabolism In Vivo | Muscle | Mouse | Cancer | University of North Carolina at Chapel Hill | GC-MS |
| ST000895 | AN001457 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Serum Metabolism In Vivo using Non-Targeted Metabolomics Analysis | Blood | Mouse | Cancer | University of North Carolina at Chapel Hill | GC-MS |
| ST000893 | AN001455 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Metabolism In Vivo | Muscle | Mouse | Cancer | University of North Carolina at Chapel Hill | GC-MS |
| ST000623 | AN001820 | Non-targeted Metabolomics Analysis of Golden Retriever Muscular Dystrophy-Affected Muscles Reveals Alterations in Arginine and Proline Metabolism, and Elevations in Glutamic and Oleic Acid In Vivo | Muscle | Dog | Muscular dystrophy | University of North Carolina at Chapel Hill | GC-MS |
| ST000586 | AN000901 | Evaluation of specific concentrations for use in experimental protocol | Blood | Human | Duke University | GC-MS | |
| ST000576 | AN000886 | Effects of the Kinase Inhibitor Sorafenib on Heart Metabolism In Vivo using Non-targeted Metabolomics Analysis tissue). | Muscle | Mouse | Cancer | University of North Carolina at Chapel Hill | GC-MS |
| ST000575 | AN000885 | Effects of the Kinase Inhibitor Sorafenib on Muscle Metabolism In Vivo using Non-targeted Metabolomics Analysis tissue). | Muscle | Mouse | Cancer | University of North Carolina at Chapel Hill | GC-MS |
| ST000441 | AN000692 | Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways | Plasmodium cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST000431 | AN000681 | C2C12 stretch cessation models muscle atrophy and anaplerotic changes in metabolism | Muscle | Mouse | University of North Carolina at Chapel Hill | GC-MS | |
| ST000426 | AN000676 | Non targeted metabolomics of gastrocnemius tissue samples obtained from 6 month old (adult) mice- Both Sham and after inducing lung injury | Muscle | Mouse | Lung injury | University of North Carolina;Duke University | GC-MS |
| ST000425 | AN000675 | Non targeted metabolomics of gastrocnemius tissue samples obtained from 20 month old (old) mice- Both Sham and after inducing lung injury | Muscle | Mouse | Lung injury | University of North Carolina;Duke University | GC-MS |
| ST000375 | AN000609 | Mice exercise metabolomics (part II) | Blood | Mouse | University of Michigan | LC-MS | |
| ST000373 | AN000607 | Measure change in metabolites based on diet and feeding status (part II) | Brain | Fruit fly | University of Michigan | LC-MS | |
| ST000350 | AN000566 | Metabolomic analysis on samples from rats expressing human amylin (plasma). | Blood | Rat | Diabetes | Duke University | GC-MS |
| ST000348 | AN000579 | Metabolomic analysis on samples from rats expressing human amylin (brain tissue). | Brain | Rat | Diabetes | Duke University | GC-MS |
| ST000347 | AN000563 | Metabolomic analysis on samples from rats expressing human amylin (cardiac tissue). | Muscle | Rat | Diabetes | Duke University | GC-MS |
| ST000313 | AN000499 | Muscle Clock knock out mice metabolic changes (iMSBmal1-Exp1) | Muscle | Mouse | University of Michigan | LC-MS | |
| ST000312 | AN000498 | IDH1R132H activity in glioma cell lines and tumnor tissue (2HG) | Cells | Mouse | Cancer | University of Michigan | LC-MS |
| ST000295 | AN000473 | Metabolic analysis of Human and Mouse Lung Fiboblasts | Fibroblast cells | Human | University of Michigan | LC-MS | |
| ST000295 | AN000473 | Metabolic analysis of Human and Mouse Lung Fiboblasts | Fibroblast cells | Mouse | University of Michigan | LC-MS | |
| ST000282 | AN000449 | Pilot Study 13C flux effects when RhoC or RhoA perturbed (13C BCs) | Cells | Human | University of Michigan | GC-MS/LC-MS | |
| ST000279 | AN000445 | Viral Effect on Metabolism (part II) | Epithelial cells | Human | University of Michigan | GC-MS/LC-MS | |
| ST000278 | AN000443 | Viral Effect on Metabolism (part I) | Epithelial cells | Human | University of Michigan | GC-MS/LC-MS | |
| ST000278 | AN000444 | Viral Effect on Metabolism (part I) | Epithelial cells | Human | University of Michigan | GC-MS/LC-MS | |
| ST000276 | AN000440 | IDH1 and Glioma knockdown idh1 | Glioma cells | Human | Cancer | University of Michigan | GC-MS/LC-MS |
| ST000275 | AN000438 | Metabolic analysis of Parp1 ko/wt Saline & Bleo Mouse Lung Fiboblasts and Human IPF & Normal Lung Fiboblasts (Part 2) | Fibroblast cells | Mouse | University of Michigan | LC-MS | |
| ST000274 | AN000437 | HIF 1 alpha type 2 cells metabolomics | Cells | Mouse | University of Michigan | LC-MS | |
| ST000271 | AN000434 | C13 Pyruvate Flux in 3t3 L1 | Cells | Mouse | University of Michigan | LC-MS | |
| ST000258 | AN000409 | Metabolic contribution of pSymA and pSymB megaplasmid/chromid for multipartite Sinorhizobium meliloti cultured in minimal M9 medium | Cells | Sinorhizobium | McMaster University | LC-MS | |
| ST000215 | AN000317 | Liver and Plasma metaboites for 13C-glucose load in wild type, LIRKO GTT 1 mice | Liver | Mouse | University of Michigan | GC-MS/LC-MS | |
| ST000209 | AN000311 | Glycolysis/TCA/Nucleotide_Wt_KO_TimeCourse_LPS | Macrophages | Mouse | University of Michigan | LC-MS | |
| ST000202 | AN000304 | THP1 Human Monocyte cells Project A (part II) | Mononuclear cells | Human | University of Michigan | LC-MS | |
| ST000185 | AN000284 | Fetal Lambs vascular graft Normal v Shunt LECs | Endothelial cells | Sheep | University of Michigan | GC-MS/LC-MS | |
| ST000183 | AN000281 | Metabolic analysis of Parp1 ko/wt Saline & Bleo Mouse Lung Fiboblasts and Human IPF & Normal Lung Fiboblasts (Part 3) | Fibroblast cells | Mouse | University of Michigan | LC-MS | |
| ST000182 | AN000280 | Bone Marrow Metabolomics (part I) | Bone marrow | Mouse | University of Michigan | LC-MS | |
| ST000181 | AN000279 | T cell metabolism during graft-versus-host disease(CAB 311) | T-cells | Mouse | University of Michigan | LC-MS | |
| ST000180 | AN000278 | 2 lines of pulmonary artery smooth muscle cells metabolic profile (122 vs 3633C central metabolic profile) | Smooth muscle | Sheep | University of Michigan | LC-MS | |
| ST000178 | AN000274 | T cell metabolism during graft-versus-host disease (CAB 307)-PART I | T-cells | Mouse | University of Michigan | GC-MS/LC-MS | |
| ST000176 | AN000270 | cell and liver metabolomics | Liver | Mouse | University of Michigan | GC-MS/LC-MS | |
| ST000176 | AN000271 | cell and liver metabolomics | Liver | Mouse | University of Michigan | GC-MS/LC-MS | |
| ST000174 | AN000268 | Mouse macrophages from bone marrow treatment | Macrophages | Mouse | University of Michigan | LC-MS | |
| ST000173 | AN000267 | Comparative metabolomics study of WT and iButOH tolerant E. coli | Bacterial cells | E. coli | University of Michigan | LC-MS | |
| ST000172 | AN000266 | THP1 Human Monocyte cells Project A (part I) | Mononuclear cells | Human | University of Michigan | LC-MS | |
| ST000171 | AN000265 | cell metabolomics (metabolic phenotypes of a clock mutant mouse) | Fibroblast cells | Mouse | University of Michigan | GC-MS | |
| ST000170 | AN000447 | 13C mass isotopomer analysis (LCMS flux studies) MLL-AF9 (part III) | Cells | Mouse | University of Michigan | LC-MS | |
| ST000162 | AN000254 | Yeast glycolysis in normoxia and hypoxia (150121_pkf2) | Yeast cells | Yeast | University of Michigan | LC-MS | |
| ST000159 | AN000251 | U13C-Glutamine and U13C-Glucose Flux Analysis (MFA SiHa B16F10) | Cultured cells | Human | University of Michigan | LC-MS | |
| ST000157 | AN000448 | 13C mass isotopomer analysis (LCMS flux studies) MLL-AF9 (part II) | Cultured cells | Mouse | University of Michigan | LC-MS | |
| ST000155 | AN000247 | ND/HSD sated/fasted fly brains | Brain | Fruit fly | University of Michigan | LC-MS | |
| ST000154 | AN000245 | Use of Aspartate Dehydrogenase by cancer cells | T-cells | Human | University of Michigan | GC-MS/LC-MS | |
| ST000147 | AN000233 | 13C targeted metabolomics | T-cells | Human | University of Michigan | GC-MS/LC-MS | |
| ST000146 | AN000232 | Noxa regulation of malate aspartate shuttle | T-cells | Human | Cancer | University of Michigan | LC-MS |
| ST000145 | AN000230 | Primary T Cell Noxa Knockdown (Donor 8) | T-cells | Human | Cancer | University of Michigan | GC-MS/LC-MS |
| ST000144 | AN000228 | Primary T Cell Baseline (Donor 5) - II | T-cells | Human | Cancer | University of Michigan | GC-MS/LC-MS |
| ST000143 | AN000226 | Metabolic analysis of Normal Mouse Lung Fiboblasts with/without TGFbeta treatment (Part 1) | Fibroblast cells | Mouse | University of Michigan | GC-MS/LC-MS |
